Loading organizations...
Loading organizations...
Biopharmaceutical company developing antibody therapeutics for cancer.
Apexigen has raised $158.0M across 3 funding rounds.
Apexigen has raised $158.0M in total across 3 funding rounds.
Apexigen has raised $158.0M in total across 3 funding rounds.
Apexigen's investors include Decheng Capital, Oceanpine Capital, Karen Liu, Dan Zabrowski, SV Tech Ventures, VI Ventures, George J. Lee, CDIB Capital Group, Sycamore Ventures, Themes Investment Partners, WSR Capital.
Apexigen has raised $158.0M across 3 funding rounds. Most recently, it raised $65.0M Series C Extension in March 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 24, 2020 | $65.0M Series C Extension | Decheng Capital, Oceanpine Capital | |
| Aug 8, 2018 | $73.0M Series B / Series C | Karen Liu, Dan Zabrowski, SV Tech Ventures, VI Ventures | |
| Aug 8, 2013 | $20.0M Series A | George J. Lee | CDIB Capital Group, Sycamore Ventures, Themes Investment Partners, WSR Capital |